H.I.G. BioHealth Partners

What is H.I.G. BioHealth Partners?

H.I.G. BioHealth Partners, operates as a venture capital firm within H.I.G.

Capital, a leading global investment firm. Founded in 2011 and based in Miami, Florida, H.I.G.

BioHealth Partners specializes in providing growth equity, with a focus on the healthcare sector. They have a distinct investment strategy that aims at working with growth-stage healthcare companies to enhance patient outcomes while simultaneously reducing overall healthcare costs.

Their seasoned investment team holds extensive and diverse experience across various domains including pharma, biotech, medical devices, diagnostics, and related services. They leverage over 500 dedicated investment professionals and a global presence with 19 offices worldwide, channeling focused value creation expertise that is generally inaccessible to mid-sized organizations.

The HealthBridge fund, in particular, targets investments in medical devices, biopharmaceuticals, digital health, diagnostics, and associated services sectors. With an investment reach that encompasses companies operating in software, IT, education, FinTech, hardware manufacturing, IoT, HealthTech, medical devices, life sciences, and more, the fund aims to strategically contribute to the growth of these entities.

Aligning with their strategy, they support control investments and have a portfolio boasting over 26 growth investments all within the healthcare sector.

Moreover, H.I.G. BioHealth Partners is committed to responsible investment practices by integrating environmental, social, and governance (ESG) considerations into their investment process. Their robust ESG framework reflects their dedication to driving improved long-term sustainable results.

H.I.G. BioHealth Partners invests with a minimum and a maximum of $60 million, positioning itself as a significant player for mid-market companies seeking growth capital.